Patent Assignment
Reel/Frame 069114/0705
Change of Name
Recorded: 2024-10-07
Pages: 4
Assignor
GEMOAB GMBH
Executed: 2021-11-30
Assignee
AVENCELL EUROPE GMBH
TATZBERG 47, DRESDEN, 01307, GERMANY
Covered Property
(1)
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer, Infections and Autoimmune Disorders
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 4, 2024
From: AVENCELL THERAPEUTICS, INC.
To: BXLS V - DIAMANT L.P., AS COLLATERAL AGENT
Reel/Frame 066026/0610 →
Change of Name
Oct 7, 2024
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 069826/0516 →
Assignment of Assignor's Interest
Oct 7, 2024
From: EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 068814/0770 →
Release of Security Interest
Oct 18, 2024
From: BXLS V – DIAMANT L.P.
To: AVENCELL THERAPEUTICS, INC.
Reel/Frame 068941/0187 →